BioTek Instruments Expands into Switzerland
News Jan 27, 2010
BioTek Switzerland was created from a previous partnership with Witec AG in Littau, Switzerland and will be managed by Margrit Limacher, Witec’s founder. Ms. Limacher will also continue management of the existing Witec AG with their focus on life science products at the same location.
“This new company is a logical result of Witec’s successful BioTek division business operations, and is expected to offer the same level of professional service and support for future growth,” noted Margrit Limacher. “Our customers will continue to have unrestricted and competent service and support when evaluating BioTek’s microplate instrumentation solutions.”
Briar Alpert, BioTek President and CEO added, “This enhanced business relationship will allow BioTek Switzerland to be well-connected to BioTek USA’s information systems with complete access to the company’s global scientific and application resources. Ultimately, this means enhanced customer satisfaction for our Swiss customers.”
BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. BioTek instrumentation is used to aid in the advancement of life science research, facilitate the drug discovery process and to enable cost-effective quantification of disease relevant molecules in the clinic.
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Worldwide Clinical Trials Receives 2018 CRO Leadership AwardsNews
Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.READ MORE
WuXi Biologics to Invest in Biologics Manufacturing Facility in SingaporeNews
WuXi Biologics' first overseas site in Asia.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018